HONG KONG (Reuters) -China’s central bank chief said on Monday the government will support moderately loose monetary policy to maintain ample liquidity
BEIJING (Reuters) – China’s export growth picked up steam in December, while imports recovered, closing out the year on a positive note
SHANGHAI (Reuters) – China stepped up its policy measures on Monday to defend a weakening yuan by relaxing rules to allow more
Investing.com– Asian stocks fell sharply on Monday led by losses in Australian and Hong Kong shares as investors reassessed the likelihood of
(Reuters) – Proxy advisory firm Ownership Matters said on Monday it recommends that shareholders of Sigma Healthcare vote in favour of Chemist
By Rae Wee SINGAPORE (Reuters) – The dollar began the week on a strong note on Monday, leaving its peers languishing near multi-year
(Refiles to fix payrolls report story link in paragraph 1) By Wayne Cole SYDNEY (Reuters) -Asian shares slipped on Monday while the dollar held
By Tim Hepher, Joanna Plucinska and Padraic Halpin DUBLIN (Reuters) – Financiers and lessors who make the global air travel industry tick gather
Investing.com– Goldman Sachs analysts said they now expect the Federal Reserve to cut interest rates twice this year, down from their prior
By Marc Jones and Chris Mfula LONDON (Reuters) -Zambia’s Securities and Exchange Commission (SEC) has sanctioned Standard Chartered (OTC:SCBFF) for mis-selling a Chinese
HONG KONG (Reuters) – Shares of China’s Shimao Group dropped 15% to HK$0.73 on Monday, their lowest since Sept. 26, after the
By Nikita Maria Jino (Reuters) – Premier Investments dived to a near one-year low on Monday and was set for the worst day
By Joey Roulette CAPE CANAVERAL, Florida (Reuters) -Jeff Bezos in an interview with Reuters on Sunday said he does not think SpaceX CEO
Investing.com– Stifel analysts said in a recent note that logistics and freight firms with exposure to North American trade were likely to
TOKYO (Reuters) – Japan Prime Minister Shigeru Ishiba asked U.S. President Joe Biden to allay concerns in the Japanese and U.S. business
Investing.com– Johnson & Johnson (NYSE:JNJ) is considering a bid to acquire biopharmaceutical company Intracellular Th (NASDAQ:ITCI), Bloomberg News reported on
